Pseudomonas aeruginosa exoenzyme S is a mitogen but not a superantigen for human T lymphocytes

Infection and Immunity

Volumn 66, Issue 7, 1998, Pages 3072-3079

  Bruno, Tony F ^a   Buser, Deborah E ^a   Syme, Rachel M ^a   Woods, Donald E ^a   Mody, Christopher H ^a  

^a UNIVERSITY OF CALGARY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL ENZYME; EXOENZYME S; MITOGENIC AGENT; SUPERANTIGEN; UNCLASSIFIED DRUG;

ARTICLE; BACTERIAL VIRULENCE; CONTROLLED STUDY; CYSTIC FIBROSIS; HELPER CELL; HUMAN; HUMAN CELL; INFLAMMATION; LUNG INJURY; LYMPHOCYTE PROLIFERATION; OPPORTUNISTIC INFECTION; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION;

EID: 0031816676     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.66.7.3072-3079.1998     Document Type: Article

References (50)

1. Abe, J., J. Forrester, T. Nakahara, J. A. Lafferty, B. L. Kotzin, and D. Y. Leung. 1991. Selective stimulation of human T cells with streptococcal erythrogenic toxins A and B. J. Immunol. 146:3747-3750.
2. Andersson, J., S. Nagy, L. Bjork, J. Abrams, S. Holm, and U. Andersson. 1992. Bacterial toxin-induced cytokine production studied at the single-cell level. Immunol. Rev. 127:69-96.
3. Azzawi, M., P. W. Johnston, S. Majumdar, A. B. Kay, and P. K. Jeffrey. 1992. T lymphocytes and activated eosinophils in airway mucosa in fatal asthma and cystic fibrosis. Am. Rev. Respir. Dis. 145:1477-1482.
4. Bacon, K. B., B. A. Premack, P. Gardner, and T. J. Schall. 1995. Activation of dual T cell signalling pathways by the chemokine RANTES. Science 269:1727-1730.
5. Biselli, R., P. M. Matricardi, R. D'Amelio, and A. Fattorossi. 1992. Multiparametric flow cytometnc analysis of the kinetics of surface molecule expression after polyclonal activation of human peripheral blood T lymphocytes. Scand. J. Immunol. 35:439-447.
6. Cebrián, M., E. Yagüe, M. Rincón, M. López-Botet, M. O. de Landázuri, and F. Sánchez-Madrid. 1988. Triggering of T cell proliferation through AIM, an activation inducer molecule expressed on activated human lymphocytes. J. Exp. Med. 168:1621-1637.
7. Clement, L. T., P. E. Vink, and G. E. Bradley. 1990. Novel immunoregulatory functions of phenotypically distinct subpopulations of CD4+ cells in the human neonate. J. Immunol. 145:102-108.
8. Coburn, J. 1992. Pseudomonas aeruginosa exoenzyme S. Curr. Top. Microbiol. Immunol. 175:133-143.
9. ras and related proteins by Pseudomonas aeruginosa exoenzyme S. Infect. Immun. 159:4259-4262.
10. Crabtree, G. R. 1989. Contingent regulatory events in T lymphocyte activation. Science 243:355-361.
11. Dagli, E., J. A. Warner, C. R. Besley, and J. O. Warner. 1992. Raised serum soluble interleukin-2 receptor concentrations in cystic fibrosis patients with and without evidence of lung disease. Arch. Dis. Child. 67:479-481.
12. Dellabona, P., J. Peccoud, J. Kappler, P. Marrack, C. Benoist, and D. Mathis. 1990. Superantigens interact with MHC class II molecules outside of the antigen groove. Cell 62:1115-1121.
13. Gebel, H. M., J. R. Scott, C. A. Parvin, and G. E. Rodney. 1983. In vitro immunization to KLH. II. Limiting dilution analysis of antigen-reactive cells in primary and secondary cultures. J. Immunol. 130:29-32.
14. Gillis, S., M. M. Ferm, W. Ou, and K. A. Smith. 1978. T cell growth factor: parameters of production and a quantitative microassay for activity. J. Immunol. 120:2027-2032.
15. Grimwood, K., M. To, H. R. Rabin, and D. E. Woods. 1989. Inhibition of Pseudomonas aeruginosa exoenzyme expression by subinhibitory antibiotic concentrations. Antimicrob. Agents Chemother. 33:41-47.
16. Grimwood, K., M. To, R. A. Semple, H. R. Rabin, P. A. Sokol, and D. E. Woods. 1993. Elevated exoenzyme expression by Pseudomonas aeruginosa is correlated with exacerbations of lung disease in cystic fibrosis. Pediatr. Pulmonol. 15:135-139.
17. Hanzel, Z. T., S. Levin, Z. Dolphin, M. Schlesinger, T. Hahn, Y. Altman, B. Scheeler, A. Shenyour, and N. Trainin. 1980. Immune competence in newborn lymphocytes. Pediatrics 65:491-496.
18. + T cells. Eur. J. Immunol. 19:771-773.
19. Hunig, T. 1984. The role of accessory cells in polyclonal T cell activation. III. No requirement for recognition of H-2 encoded antigens on accessory cells. Eur. J. Immunol. 14:483-489.
20. Julius, M. H., E. Simpson, and L. A. Herzenberg. 1973. A rapid method for the isolation of functional thymus-derived murine lymphocytes. Eur. J. Immunol. 3:645-649.
21. Kanof, M. E. 1996. Isolation of T cells using rosetting procedures, p. 7.2.3-7.2.4. In J. E. Coligan, A. M. Kruisbeek, D. H. Margulies, E. M. Shevach, and W. Strober (ed.), Current protocols in immunology. John Wiley & Sons, Inc., New York, N.Y.
22. Kappler, J., B. Kotzin, L. Herron, E. W. Gelfand, R. D. Bigler, A. Boylston, S. Carrel, D. N. Posnett, and P. Marrack. 1989. Vβ-specific stimulation of T cells by staphylococcal toxins. Science 244:811-813.
23. Kawabe, Y., and A. Ochi. 1990. Selective anergy of Vβ8+ T cells in Staphylococcus enterotoxin B-primed mice. J. Exp. Med. 172:1065-1070.
24. Kishimoto, H., C. D. Surh, and J. Sprent. 1995. Upregulation of surface markers on dying thymocytes. J. Exp. Med. 181:649-655.
25. Konstan, M. W., and M. Berger. 1993. Infection and inflammation of the lung in cystic fibrosis, p. 219-276. In P. B. Davis (ed.), Cystic fibrosis, 1st ed. Marcel Dekker Inc., New York, N.Y.
26. Larsson, E., K. F. Lindahl, J. Langhorne, and A. Coutinho. 1981. Quantitative studies on concanavalin A-induced, TCGF-reactive cells. I. Correlation between proliferation and lectin dependent cytolytic activity. J. Immunol. 127:1081-1085.
27. Licastro, F., M. Chiricolo, L. Barbieri, F. Stripe, A. Falasca, C. A. Rossi, and C. Franceschi. 1983. Effect of 32 purified animal and plant lectins on human T lymphocytes, p. 293-302. In T. C. Bog-Hansen and G. A. Spengler (ed.), Lectins: biology-biochemistry, clinical, biochemistry, vol. 3. Walter de Gruyter, Berlin, Germany.
28. Licastro, F., E. J. Davis, and M. C. Morini. 1993. Lectins and superantigens: membrane interactions of these compounds with T lymphocytes affect immune responses. Int. J. Biochem. 25:845-852.
29. MacDonald, H. R., S. Baschieri, and R. K. Lees. 1991. Clonal expression precedes anergy and death of Vβ8+ peripheral T cells responding to staphylococcal enterotoxin B in vivo. Eur. J. Immunol. 21:1963-1966.
30. Maino, V. C., M. A. Suni, and J. Ruitenberg. 1995. Rapid flow cytometric method for measuring lymphocyte subset activation. Cytometry 20:127-133.
31. Mann, D. L., F. Lasane, M. Popovic, L. O. Arthur, W. G. Robey, W. A. Blattner, and M. J. Newman. 1987. HTLV-III large envelope protein (gpl20) suppresses PHA-induced lymphocyte blastogenesis. J. Immunol. 138:2640-2644.
32. Mody, C. H., D. E. Buser, R. M. Syme, and D. E. Woods. 1995. Pseudomonas aeruginosa exoenzyme S induces proliferation of human T lymphocytes. Infect. Immun. 63:1800-1805.
33. Olson, J. C., E. M. McGuffie, and D. W. Frank. 1997. Effects of differential expression of the 49-kilodalton exoenzyme S by Pseudomonas aeruginosa on cultured eukaryotic cells. Infect. Immun. 65:248-256.
34. Pitcher-Wilmott, R. W., R. J. Levinsky, I. Gordon, M. W. Turner, and D. J. Mathew. 1982. Pseudomonas infection, allergy, and cystic fibrosis. Arch. Dis. Child. 57:582-586.
35. Porwoll, J. M., H. M. Gebel, G. E. Rodey, and R. B. Markham. 1983. In vitro response of human T cells to Pseudomonas aeruginosa. Infect. Immun. 40: 670-674.
36. Prince, H. E., J. York, and E. R. Jensen. 1992. Phenotypic comparison of the three populations of human lymphocytes defined by CD45RO and CD45RA expression. Cell. Immunol. 145:254-262.
37. Regelmann, W. E., G. R. Elliott, W. J. Warwick, and C. C. Clawson. 1990. Reduction of sputum Pseudomonas aeruginosa density by antibiotics improves lung function in cystic fibrosis more than do bronchodilators and chest physiotherapy alone. Am. Rev. Respir. Dis. 141:914-921.
38. Scherer, M. T., L. Ignatowicz, G. M. Winslow, J. W. Kappler, and P. C. Marrack. 1993. Superantigens: bacterial and viral proteins that manipulate the immune response. Annu. Rev. Cell Biol. 9:101-128.
39. See, R. H., G. Krystal, and A. W. Chow. 1992. Receptors for toxic shock syndrome toxin-1 and Staphylococcal enterotoxin A on human blood monocytes. Can. J. Microbiol. 38:937-944.
40. Shenker, B. J., and S. Datar. 1995. Fusobacterium nucleatum inhibits human T-cell activation by arresting cells in the mid-G1 phase of the cell cycle. Infect. Immun. 63:4830-4836.
41. Sopori, M. L., Y. L. Hurt, S. Cherian, A. M. Kaplan, and T. Diamantstein. 1987. Differential requirement for accessory cells in polyclonal T-cell activation. Cell. Immunol. 105:174-186.
42. Sorensen, R. U., R. C. Stern, P. A. Chase, and S. H. Polmar. 1981. Changes in lymphocyte reactivity to Pseudomonas aeruginosa in hospitalized patients with cystic fibrosis. Am. Rev. Respir. Dis. 123:37-41.
43. Stiehm, E. R., H. S. Winter, and Y. J. Bryson. 1979. Cellular immunity in the human newborn. Pediatrics 64:814-821.
44. Testi, R., J. H. Phillips, and L. L. Lanier. 1989. Leu 23 induction as an early marker of functional CD3/T cell antigen receptor signalling. J. Immunol. 142:1854-1860.
45. Truneh, A., F. Albert, P. Golstein, and A. M. Schmitt-Verhulst. 1985. Early steps of lymphocyte activation bypassed by synergy between calcium ionophores and phorbol ester. Nature 313:318-320.
46. Webb, S., C. Morris, and J. Sprent. 1990. Extrathymic tolerance of mature T cells: clonal elimination as a consequence of immunity. Cell 63:1249-1256.
47. Woods, D. E. Unpublished data.
48. Woods, D. E., and P. A. Sokol. 1985. Use of transposon mutants to assess the role of exoenzyme S in chronic pulmonary disease due to Pseudomonas aeruginosa. Eur. J. Clin. Microbiol. 4:163-169.
49. Woods, D. E., M. S. Schaffer, H. R. Rabin, G. D. Campbell, and P. A. Sokol. 1986. Phenotypic comparison of Pseudomonas aeruginosa strains isolated from a variety of clinical sites. J. Clin. Microbiol. 24:260-264.
50. Woods, D. E., and J. Que. 1987. Purification of Pseudomonas aeruginosa exoenzyme S. Infect. Immun. 55:579-586.